




 |
  |
| |
|
| |
Role
of Hypermethylation of DAP-Kinase CpG Island in the Development of Thyroid
Lymphoma
|














|
|
Shin-ichi Nakatsuka,
Tetsuya Takakuwa, Yasuhiko Tomita, Hideaki Miwa, Fumio Matsuzuka, and Katsuyuki
Aozasa
|
| |
|
| |
Department
of Pathology (SN, TT, YT, HM, KA), Osaka University Graduate School of Medicine,
Osaka, and Section of Surgery (FM), Kuma Hospital, Kobe, Japan
|
| |
|
| |
Death-associated protein-kinase (DAP-Kinase) is a serine/threonine kinase
with a death domain that is involved in apoptosis induced by interferon-g,
TNF-a, and Fas ligand. Epigenetic down-regulation
of DAP-Kinase gene expression by hypermethylation of its promoter region
was reported in B-cell malignancies. Previous pathoepidemiologic studies
indicated that thyroid lymphoma (TL) evolves among active lymphoid cells
in chronic lymphocytic thyroiditis (CLTH). With use of methylation-specific
polymerase chain reaction, the methylation status of DAP-Kinase CpG island
was examined in thyroid lesions of 19 cases with TL and 9 with CLTH. The
frequency of methylation was higher in TL cases (16 of 19, 84.2%) than
in CLTH cases (2 of 9, 22.2%) (p < 0.01). DNA extracted from peripheral
blood leukocytes from TL and CLTH cases never showed methylation, indicating
that the methylation occurred somatically in the lesional lymphocytes
in thyroid. These findings suggested that methylation of the DAP-Kinase
promoter region might be involved in the development of TL from CLTH.
|
| |
|
| |
 |